Literature DB >> 21317812

Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.

Ryosuke Hosokai1, Chihaya Imai, Takayuki Takachi, Sakiko Yoshida, Haruko Iwabuchi, Masaru Imamura, Makoto Uchiyama.   

Abstract

We describe a 14-year-old boy who exhibited left palatine tonsillar enlargement after 6 cycles of aggressive chemotherapy for diffuse large B-cell lymphoma of the right palatine tonsil. The cervical computed tomography scan at 4 months after completion of chemotherapy revealed enlargement of the left palatine tonsil in addition to the thymus without any clinical symptoms. The F-fluorodeoxyglucose positron emission tomography indicated focal areas of strong F-fluorodeoxyglucose uptake in the left palatine tonsil. Histologic examination confirmed tonsillar hyperplasia with no evidence of recurrence. Reactive tonsillar hyperplasia after chemotherapy is rarely reported.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317812     DOI: 10.1097/MPH.0b013e3181f69205

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Rebound adenoid hyperplasia after chemotherapy in pediatric patients with head and neck lymphoma: MR imaging findings.

Authors:  Hiroki Kato; Masayuki Matsuo; Michio Ozeki; Toshiyuki Fukao
Journal:  Jpn J Radiol       Date:  2016-07-19       Impact factor: 2.374

2.  Reactive tonsillar enlargement showing strong 18F-FDG uptake during the follow-up of follicular lymphoma.

Authors:  Patricia do Socorro Queiroz Feio; Camilla Borges Ferreira Gomes; Alexandre Simões Nogueira; Luciana Yamamoto Almeida; José Vassallo; Fernando Augusto Soares; Oslei Paes Almeida; Jorge Esquiche León
Journal:  Head Neck Pathol       Date:  2012-09-26

3.  18FDG-PET/CT Specificity for the Detection of Lymphoma Recurrence in the Tonsils.

Authors:  Jonathan D West; Mary E Kim; Dorian M Lapalma; Maria Vergara-Lluri; Peter Conti; Tamara N Chambers; Mark S Swanson
Journal:  OTO Open       Date:  2021-11-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.